SCHEMBL13600067

SCHEMBL13600067

CC(c1ccncc1)N1CCN(C(=O)c2ccc(-c3ccccc3)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
FASN P49327 1/20 0.55
SLC6A7 Q99884 6/20 0.54
ALDH1A1 P00352 2/20 0.54
TSHR P16473 2/20 0.54
MAPK1 P28482 3/20 0.54
HPGD P15428 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.52
USP2 O75604 3/20 0.52
CYP3A4 P08684 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
LMNA P02545 1/20 0.51
CYP2C19 P33261 2/20 0.51
HIF1A Q16665 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
MAOB P27338 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8163040 0.81 POLB (0.69) POLBMEN1KMT2AFASNSLC6A7
SCHEMBL208307 0.80 ALDH1A1 (0.51) KMT2AALDH1A1CYP2D6
SCHEMBL19562096 0.79 MAOB (0.58) POLBMEN1KMT2AFASNALDH1A1
SCHEMBL14452939 0.79 EPHX2 (0.60) POLBMEN1KMT2ASLC6A7ALDH1A1
SCHEMBL3573771 0.78 SLC6A7 (0.81) POLBMEN1KMT2ASLC6A7ALDH1A1
SCHEMBL10721898 0.78 MAPK1 (0.85) POLBMEN1KMT2AFASNSLC6A7
SCHEMBL31350856 0.77 MAOB (0.82) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL14465259 0.77 ALDH1A1 (0.42) POLBMEN1KMT2AALDH1A1USP2
SCHEMBL19885179 0.76 POLB (0.69) POLBMEN1KMT2AFASNSLC6A7
SCHEMBL13149502 0.74 TSHR (0.64) POLBMEN1KMT2AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638531-B2 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists SCHERING CORPORATION (US) 2009-12-29 US disclosed
US-7638531-B2 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists SCHERING CORPORATION (US) 2009-12-29 US disclosed
US-20070167435-A1 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists SCHERING CORPORATION 2007-07-19 US disclosed
US-20070167435-A1 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists SCHERING CORPORATION 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167435-A1 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists HRH4, HRH3, HRH2 POLB 3858/4885MEN1 3211/4885KMT2A 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.